Introduction {#s001}
============

A[fter a traumatic spinal cord injury]{.smallcaps} (tSCI), patients often experience one or more adverse events (AEs)^[@B1]^---i.e., medical complications or secondary diagnoses, which are commonly referred to as secondary complications and can occur at any point after injury, such as during acute care, rehabilitation care, and throughout the rest of a person\'s life. Experiencing AEs during the period of initial hospitalization can disrupt care and negatively impact outcomes.^[@B2]^ Identifying persons who may be at an increased risk for experiencing AEs^[@B1]^ will help care providers pinpoint who may benefit the most from preventative interventions.

Patient factors have been shown to be associated with risk of specific AEs including urinary tract infections (UTI),^[@B2],[@B7],[@B10]^ pneumonia,^[@B2],[@B7],[@B11]^ delirium,^[@B2],[@B7],[@B12],[@B13]^ and cardiac complications.^[@B10]^ Advancing age is a significant predictor for increased risk of AEs.^[@B1]^ Gender differences in AEs were also found, with males being at higher general risk of AEs,^[@B5],[@B7]^ respiratory complications,^[@B10]^ and pressure ulcers (PU),^[@B14]^ and females at higher risk of UTI,^[@B10]^ delirium,^[@B7]^ and deep vein thrombosis.^[@B13]^

Injury factors such as high energy injury mechanisms,^[@B2],[@B7]^ presence of injuries concurrent to SCI as measured by Injury Severity Score (ISS),^[@B6],[@B11],[@B15]^ Glasgow Coma Scale (GCS),^[@B10],[@B16]^ or presence/number of other major injuries^[@B7],[@B10]^ have been shown to increase the risk of AEs. Severity of SCI, as measured by the International Standards for Neurological Classification of SCI (ISNCSCI),^[@B17]^ also affects risk of AEs because the anatomical region and the completeness of injury affect which body systems are disrupted and the motor and sensory impairment of the patient. More severe injuries and higher level injuries elevate the risk of AEs generally^[@B8],[@B11],[@B16],[@B18]^ and specific types of AEs including pneumonia and other respiratory complications,^[@B11]^ autonomic dysreflexia,^[@B19]^ PU,^[@B20]^ and pain.^[@B21]^

Increased risk of AEs in the general spine population has also been linked to the presence/number of comorbidities^[@B3]^ and higher Charlson^[@B18]^ and Elixhauser comorbidity index scores.^[@B6],[@B15]^ Specific associations have been reported between: diabetes and cardiac complications, post-operative infections, hematoma, and risk of complications^[@B22]^; previous smoking and complications^[@B16]^; anemia and respiratory complications^[@B10]^; psychiatric disorder and acute onset depression^[@B23]^; obesity and complications^[@B24]^; and pulmonary disease/infection and previous PU have been linked to risk of PU.^[@B25]^

Although there are many reported associations of comorbidities and AEs in the literature, there has been little focus on potentially modifiable comorbidities that, if appropriately managed, may reduce the risk of relevant AEs in acute care, saving both in costs and burden on patients. Using data from prospectively collected data sources, the objectives of this study were to: (1) validate existing interactions between patient factors (nonmodifiable factors) and AEs in the acute phase of SCI care; and (2) identify potentially modifiable comorbid conditions related to previously identified common AEs that may encourage future management strategies to reduce AE risk.

Methods {#s002}
=======

Study design {#s003}
------------

Adults with acute tSCI who were admitted to an acute specialized spine facility in a Level I trauma center (the study site, Vancouver General Hospital) and who were enrolled in the Rick Hansen SCI Registry (RHSCIR) and had AE data collected using the Spine Adverse Events Severity (SAVES)^[@B1],[@B26]^ system, which may record no experienced AEs, were included in the study cohort (2006--2014). Prospective SAVES data collection was piloted in 2006 and implemented in 2008. The RHSCIR is a prospective observational database that collects data on adult patients who have sustained a new tSCI and are admitted to a participating site. The RHSCIR includes data extracted from patient chart review and linkage to hospital administration databases (using the *International Classification of Diseases, Tenth Revision* \[ICD 10\] coding system)^[@B27]^ from the Discharge Administration Database (DAD). Institutional Research Ethics Board approval was obtained before enrolling patients. Full details of the RHSCIR have been published elsewhere.^[@B28]^

Previously reported analyses on a smaller cohort of patients (*n* = 171) with SAVES data^[@B2]^ were repeated to validate the results on a larger sample in this study, which included the original sample. In keeping with the previous methodology established by Street and associates,^[@B2]^ analyses were performed to validate the most common AEs, and the association of top AEs found by Street and associates^[@B2]^ (delirium, pneumonia, neuropathic pain \[NP\], PU, UTI) and total number of AEs with patient and injury (nonmodifiable) factors. New analyses were performed to identify potentially modifiable comorbidities relating to these common AEs. Inclusion criteria included patients having both comorbidity and AE data. Patients admitted to the study site more than seven days post-injury were excluded.

Study variables {#s004}
---------------

Age, gender, mechanism of injury (fall vs. nonfall), neurological severity and level of injury measured at admission by the American Spinal Injury Association (ASIA) Impairment Scale (AIS) of the ISNCSCI^[@B17]^ were the nonmodifiable factors considered in the analyses.

Data on comorbidities collected for the RHSCIR were categorized to ensure that the same comorbidity was counted only once for the same patient. Count of comorbidities was calculated by summing all unique comorbidities of each patient.

Potentially modifiable comorbidities in the acute setting included: health-related conditions (hypertension, diabetes, Parkinson disease, multiple sclerosis, and epilepsy), substance (alcohol, drug) use/withdrawal, psychiatric conditions (delirium, schizophrenia, nonorganic psychosis, bipolar, depressive episode, mood disorder, anxiety, obsessive-compulsive \[anankastic\] personality disorder, history of self-harm, gender identity disorder). The comorbidities were grouped into the three categories (health-related conditions, substance use/withdrawal, and psychiatric conditions) based on their clinical symptoms and causes.

The AE data were obtained from the prospective, validated SAVES instrument used to collect AE data (type of AE if present, or absence of AE) during the inpatient stay at the study site.^[@B26]^ The SAVES instrument has been described in detail elsewhere.^[@B1],[@B26]^ Where the same AE was recorded more than once for a patient, it was counted once. Count/number of AEs was calculated by summation of all unique AEs (main SAVES items) of each patient.

Statistical analysis {#s005}
--------------------

Descriptive statistics were used to describe patient and injury factors and the AEs. To determine the association between number of AEs experienced and nonmodifiable factors, a negative binomial regression model was applied with outliers removed based on the Tukey rule (i.e., 1.5 × interquartile range rule). The association between each of the common five AEs experienced and nonmodifiable factors were modeled using multiple logistic regressions with a stepwise variable selection method (*p* values for a variable to enter and stay in the model set to 0.25 and 0.10, respectively). Initial models included nonmodifiable factors such as age at injury, gender, mechanism of injury (fall; nonfall), AIS (AIS A; AIS B,C; AIS D) and neurological level (high cervical, C1--C4; low cervical, C5--T1; thoracic/thoracolumbar/lumbar/sacral, T2--S5) as covariates. Final models included statistically significant covariates but age, AIS and neurological level were included regardless of their statistical significance because they were considered to be clinically relevant.

Bivariate analyses were performed to test associations between AEs and potentially modifiable comorbidities using the χ^[@B2]^ test unless the expected counts were less than five, in which case the Fisher\'s exact test was performed. Bivariate associations were re-examined with multivariate logistic regressions to adjust for significant nonmodifiable risk factors of each AE identified from the final models. Age at injury, AIS and neurological level were always included because of their clinical significance.

Goodness of fit tests were performed for all models and Akaike Information Criterion was used for model selection. Associations with a *p* value \<0.05 were considered statistically significant. All analyses were performed using SAS software, Version 9.4 of the SAS System for Windows. ^©^2013. SAS Institute Inc., Cary, NC.

Results {#s006}
=======

Of the 528 patients admitted to the study site between 2006 and 2014 with AE data collected, 52 were ineligible and 32 were eligible but excluded, leaving a final study cohort of 444 patients ([Fig. 1](#f1){ref-type="fig"}). [Table 1](#T1){ref-type="table"} describes the patient and injury factors of the study cohort.

![Sample size flow chart for the study analysis. Collection of AE data with Spine Adverse Events Severity system was piloted in 2006 and implemented in 2008. RHSCIR, Rick Hansen Spinal Cord Injury Registry; AEs, adverse events.](fig-1){#f1}

###### 

[Patient Characteristics in the Study Cohort]{.smallcaps}

  *Variable*                                                            *Value*
  --------------------------------------------------------------------- -------------
  Number of patients in study cohort                                    444
  Age at injury; mean ± SD                                              47.5 ± 20.3
  Male gender; n (%)                                                    352 (79.3)
  Mechanism of injury; n (%)                                            
   Falls                                                                189 (44.4)
   Non-falls                                                            237 (55.6)
  ASIA Impairment Scale (AIS); n (%)                                    
   AIS A                                                                167 (39.4)
   AIS B/C                                                              133 (31.4)
   AIS D                                                                124 (29.2)
  Neurological level of injury; n (%)                                   
   High cervical, C1--C4                                                139 (32.5)
   Low cervical, C5--T1                                                 135 (31.5)
   Thoracic/thoracolumbar/lumbar/sacral, T2--S5                         154 (36.0)
  Counts of comorbidities; n (%)                                        
   None                                                                 195 (43.9)
   One or two                                                           192 (43.2)
   Three or more                                                        57 (12.8)
  Potentially modifiable comorbidities; n (%)                           
   Health-related condition^[\*](#tf1){ref-type="table-fn"}^            110 (24.8)
   Substance use/withdrawal                                             68 (15.3)
   Psychiatric condition                                                35 (7.9)
  Counts of adverse events; n (%)                                       
   None                                                                 92 (20.7)
   One or two                                                           183 (41.2)
   Three or more                                                        169 (38.1)
  Time from injury to admission to study site (hours); median (Q1,Q3)   8.5 (4, 16)

Health-related condition included hypertension, diabetes, Parkinson disease, multiple sclerosis, and epilepsy.

SD, standard deviation; ASIA, American Spinal Injury Association; Q1, first quartile; Q3, third quartile.

The mean age of patients in the cohort was 47.5 ± 20.3 years, 79% were male, and 44% had fall-related injuries. Fifty-six percent of the patients had at least one reported comorbidity, and 13% had three or more. Of the potentially modifiable comorbidities, 25% of patients had a health-related condition, 15% had a substance use/withdrawal condition, and 8% had a psychiatric condition. The incidence of comorbidities within each condition is listed in [Table 2](#T2){ref-type="table"}. Twenty-one percent of patients experienced no AE, 79% experienced at least one AE, and 38% of these had three or more.

###### 

[Incidence of the Potentially Modifiable Comorbidities]{.smallcaps}

  *Group*                     *Comorbidity*                                   *Incidence (%)*
  --------------------------- ----------------------------------------------- -----------------
  Health-related conditions   Hypertension                                    20.0
                              Diabetes                                        10.8
                              Parkinson disease/multiple sclerosis/epilepsy   1.1
  Substance use/withdrawal    Alcohol use                                     11.0
                              Drug use                                        4.7
                              Withdrawal                                      3.6
  Psychiatric conditions      Schizophrenia                                   0.9
                              Depressive disorder                             3.4
                              Anxiety                                         2.7
                              Other psychiatric conditions                    1.6

Nonmodifiable factors {#s007}
---------------------

For incidence of AEs, older age and having a more severe injury (AIS A,B/C vs. AIS D) were significantly associated with experiencing more AEs ([Table 3](#T3){ref-type="table"}). Adjusting for age and injury severity, the number of AEs would increase by 1.006 for every year older (*p* = 0.004). Patients with AIS A or AIS B/C injuries would experience about two times more AEs compared with patients with AIS D injuries (2.2 times, 1.7 times, respectively; *p* \< 0.0001). The 10 most common AEs observed were UTI, pneumonia, NP, delirium, cardiac arrest/failure/arrhythmia, dysphagia, systemic infection, PU, neurological deterioration, and superficial wound infection as shown in [Table 4](#T4){ref-type="table"}. Comparing the five AEs reported in the previous study,^[@B2]^ higher frequency was found in this study.

###### 

[A Negative Binomial Regression to Model the Impact of Patient Characteristics on the Number of Adverse Events (AEs) Experienced]{.smallcaps}

                                                                              *Number of AEs experienced*          
  ----------------------------------------------------------- ------- ------- ----------------------------- ------ --------------
  Intercept                                                   −0.18   0.13    −0.44--0.08                   0.84   0.1803
  Age at injury                                               0.006   0.002   0.002--0.01                   1.01   **0.0038**
  ASIA Impairment Scale (AIS)                                                                                      
   AIS A                                                      0.78    0.10    0.58--0.99                    2.19   **\<0.0001**
   AIS B/C                                                    0.55    0.11    0.34--0.77                    1.74   **\<0.0001**
   AIS D (reference)                                          \-      \-      \-                            \-     \-
  Neurological level of injury                                                                                     
   High cervical, C1--C4                                      0.12    0.10    −0.07--0.32                   1.13   0.2172
   Low cervical, C5--T1                                       0.15    0.10    −0.04--0.35                   1.17   0.1214
   Thoracic/thoracolumbar/lumbar/sacral, T2--S5 (reference)   \-      \-      \-                            \-     \-

Parameter estimates after exponentiation.

The number of AEs was calculated by summation of all unique AEs each patient had. Bold *p* values indicate statistical significance.

CI, confidence interval; ASIA, American Spinal Injury Association.

###### 

[Incidence of Adverse Events]{.smallcaps}

  *Adverse event*                                     *Analysis cohort (%)*   *Street and associates 2015 (%)*
  --------------------------------------------------- ----------------------- ----------------------------------
  Urinary tract infections                            42.8                    32.2
  Pneumonia                                           39.2                    32.8
  Neuropathic pain                                    31.5                    15.2
  Delirium                                            18.2                    18.7
  Cardiac arrest/failure/arrhythmia                   15.3                     
  Dysphagia                                           12.6                     
  Systemic infection                                  12.2                     
  Pressure ulcers                                     11.0                    14.6
  Neurological deterioration                          4.7                      
  Superficial wound infection                         4.7                      
  Pulmonary embolism                                  3.6                      
  Hematoma                                            3.4                      
  Deep wound infection                                3.2                      
  Intra-op hardware malposition requiring revision    2.9                      
  Intra-op airway/ventilation                         2.3                      
  Intra-op dural tear                                 2.3                      
  Deep vein thrombosis                                1.6                      
  Gastrointestinal bleeding                           1.4                      
  Dysphonia                                           1.4                      
  Intra-op massive blood loss                         1.4                      
  Allergic reaction                                   1.1                      
  Cerebrospinal fluid leak/meningocele                1.1                      
  Wound dehiscence                                    0.9                      
  Construct failure with loss of correction           0.7                      
  Intra-op hypotension                                0.7                      
  Hardware malposition requiring revision             0.5                      
  Myocardial infarction                               0.5                      
  Bone implant interface failure requiring revision   0.2                      
  Dural tear                                          0.2                      
  Intra-op allergic reaction                          0.2                      
  Intra-op cardiac                                    0.2                      
  Intra-op cord injury                                0.2                      
  Intra-op nerve root injury                          0.2                      
  Massive blood loss                                  0.2                      

Intra-op, intraoperative.

Where multiple incidents of a particular AE occur, the AE is only counted once per patient.

Individual multiple logistic regression models were used to determine patient factors (nonmodifiable risk factors) that affect the occurrence of the five AEs ([Table 5](#T5){ref-type="table"}). Adjusting for age, gender, AIS and neurological level, odds of developing a UTI increased by 1.01 for every year older (95% CI \[confidence interval\] 1.0--1.02); females were twice as likely compared with males (95% CI 1.3--3.5) to develop a UTI. Patients with AIS A or AIS B/C injuries were three times (95% CI 1.8--5.3) and two times (95% CI 1.2--3.4), respectively, more likely to develop a UTI compared with those with AIS D injuries ([Table 5](#T5){ref-type="table"}).

###### 

[Logistic Regression Analyses to Explore Nonmodifiable Factors that Affect the Occurrence of the Adverse Events as Analyzed in Street and Associates]{.smallcaps}

  *Outcome*                  *Independent variable*         *Estimate*   *Std. error*   *Odds ratio*   *95% Wald CI*   p
  -------------------------- ------------------------------ ------------ -------------- -------------- --------------- --------------
  Urinary tract infections   Intercept                      −1.49        0.35           \-             \-              \<0.0001
                             Age at injury                  0.01         0.005          1.01           1.0--1.02       **0.0233**
                             Gender                                                                                    
                              Female                        0.74         0.25           2.09           1.27--3.45      **0.0037**
                              Male (reference)              \-           \-             \-             \-              \-
                             ASIA Impairment Scale (AIS)                                                               
                              AIS A                         1.13         0.27           3.09           1.84--5.20      **\<0.0001**
                              AIS B/C                       0.67         0.27           1.96           1.15--3.35      **0.0136**
                              AIS D (reference)             \-           \-             \-             \-              \-
                             Neurological level of injury                                                              
                              C1--C4                        −0.34        0.27           0.72           0.42--1.21      0.2134
                              C5--T1                        −0.34        0.26           0.71           0.42--1.19      0.1901
                              T2--S5 (reference)            \-           \-             \-             \-              \-
  Pneumonia                  Intercept                      −3.03        0.42           \-             \-              \<0.0001
                             Age at injury                  0.008        0.006          1.01           0.99--1.02      0.1919
                             Gender                                                                                    
                              Female                        −0.62        0.29           0.54           0.30--0.95      **0.0340**
                              Male (reference)              \-           \-             \-             \-              \-
                             ASIA Impairment Scale (AIS)                                                               
                              AIS A                         2.47         0.33           11.77          6.21--22.29     **\<0.0001**
                              AIS B/C                       1.60         0.32           4.93           2.63--9.24      **\<0.0001**
                              AIS D (reference)             \-           \-             \-             \-              \-
                             Neurological level of injury                                                              
                              C1--C4                        1.15         0.30           3.18           1.75--5.77      **0.0001**
                              C5--T1                        1.24         0.30           3.44           1.93--6.14      **\<0.0001**
                              T2--S5 (reference)            \-           \-             \-             \-              \-
  Delirium                   Intercept                      −3.65        0.51           \-             \-              \<0.0001
                             Age at injury                  0.04         0.007          1.04           1.02--1.05      **\<0.0001**
                             Gender                                                                                    
                              Female                        −1.20        0.44           0.30           0.13--0.71      **0.006**
                              Male (reference)              \-           \-             \-             \-              \-
                             ASIA Impairment Scale (AIS)                                                               
                              AIS A                         0.50         0.36           1.64           0.81--3.33      0.1676
                              AIS B/C                       0.83         0.36           2.28           1.13--4.60      **0.0207**
                              AIS D (reference)             \-           \-             \-             \-              \-
                             Neurological level of injury                                                              
                              C1--C4                        −0.23        0.35           0.80           0.40--1.60      0.518
                              C5--T1                        −0.09        0.35           0.92           0.46--1.82      0.8027
                              T2--S5 (reference)            \-           \-             \-             \-              \-
  Pressure ulcers            Intercept                      −3.85        0.72           \-             \-              \<0.0001
                             Age at injury                  −0.006       0.008          0.99           0.98--1.01      0.4921
                             ASIA Impairment Scale (AIS)                                                               
                              AIS A                         2.31         0.63           10.11          2.97--34.40     **0.0002**
                              AIS B/C                       1.70         0.65           5.47           1.54--19.48     **0.0087**
                              AIS D (reference)             \-           \-             \-             \-              \-
                             Neurological level of injury                                                              
                              C1--C4                        0.17         0.44           1.18           0.50--2.80      0.7053
                              C5--T1                        0.82         0.38           2.27           1.08--4.78      **0.0314**
                              T2--S5 (reference)            \-           \-             \-             \-              \-

Neuropathic pain model was not shown because it was not significant as a whole. Bold *p* values indicate statistical significance.

Std. error, standard error; CI, confidence interval; ASIA, American Spinal Injury Association.

After adjusting for age, gender, AIS and neurological level, the odds of experiencing pneumonia were higher in males and in patients with more severe injuries or cervical injuries. Males were 1.9 times more likely compared with females (95% CI 1.1--3.3) to develop pneumonia. Patients with AIS A or AIS B/C injuries were 12 times (95% CI 6.2--22.3) or five times (95% CI 2.6°9.2), respectively, more likely compared with those with AIS D injuries, and patients with cervical injuries were three times more likely than those with thoracic/thoracolumbar/lumbar/sacral injuries to develop pneumonia (*p* = 0.0001) ([Table 5](#T5){ref-type="table"}).

The odds of developing delirium increased by 1.04 for one year increase in age (*p* \< 0.0001). Males were three times more likely compared with females (95% CI 1.4--7.7); and patients with AIS B/C were two times more likely compared with those with AIS D injuries (95% CI 1.1--4.6) to develop delirium ([Table 5](#T5){ref-type="table"}).

For developing PU, the odds were 10 times (95% CI 3--34) and five times (95% CI 1.5--19) for patients with AIS A and AIS B/C injuries, respectively, compared with those with AIS D injuries. Patients with low cervical injuries were twice as likely to develop PU than those with thoracic/thoracolumbar/lumbar/sacral injuries (95% CI 1.1--4.8) ([Table 5](#T5){ref-type="table"}). No patient or injury factors were significantly associated with development of NP.

Potentially modifiable comorbidities {#s008}
------------------------------------

[Table 6](#T6){ref-type="table"} shows the association of potentially modifiable comorbidities for the five AEs previously identified by Street et al.^[@B2]^ According to the bivariate analyses, the modifiable comorbidities related to health-related conditions were significantly associated with NP and delirium; substance use/withdrawal was significantly associated with delirium; and psychiatric conditions were significantly associated with pneumonia and NP. After adjusting for age, AIS and neurological level, and gender if statistically significant from above, only the associations between psychiatric conditions and pneumonia and between substance use/withdrawal and delirium remained significant. Psychiatric conditions increased the odds of developing pneumonia by four times (95% CI 1.6--10.5). Substance use/withdrawal conditions increased the odds of developing delirium by 2.5 times (95% CI 1.3--4.8).

###### 

[Individual Multiple Logistic Regression Models to Explore the Association of the Adverse Events as Analyzed in Street and Associates and Each Group of Potentially Modifiable Comorbidity]{.smallcaps}

  *Outcome*                  *Model*   *Independent variable*     *Estimate*   *Std. error*   *Odds ratio^[\*](#tf10){ref-type="table-fn"}^*   *95% Wald CI*   p^[\*](#tf10){ref-type="table-fn"}^
  -------------------------- --------- -------------------------- ------------ -------------- ------------------------------------------------ --------------- -------------------------------------
  Urinary tract infections   1         Health-related condition   −0.09        0.28           0.92                                             0.52--1.60      0.7538
                             2         Substance use/withdrawal   0.28         0.28           1.32                                             0.76--2.28      0.3256
                             3         Psychiatric conditions     −0.31        0.39           0.73                                             0.34--1.58      0.4276
  Pneumonia                  1         Health-related condition   0.22         0.31           1.26                                             0.69--2.29      0.4593
                             2         Substance use/withdrawal   0.41         0.30           1.50                                             0.83--2.72      0.1811
                             3         Psychiatric conditions     1.41         0.48           4.08                                             1.59--10.51     **0.0035**
  Delirium                   1         Health-related condition   0.009        0.33           0.99                                             0.51--1.91      0.9782
                             2         Substance use/withdrawal   0.93         0.32           2.54                                             1.34--4.80      **0.0042**
                             3         Psychiatric conditions     −0.30        0.54           0.74                                             0.26--2.16      0.5847
  Pressure ulcers            1         Health-related condition   −0.68        0.48           0.51                                             0.20--1.29      0.1539
                             2         Substance use/withdrawal   −0.51        0.50           0.60                                             0.22--1.61      0.3102
                             3         Psychiatric conditions     −0.54        0.64           0.58                                             0.17--2.07      0.4042

Adjusted for age at injury, neurological severity (American Spinal Injury Association Impairment Scale) and level, and gender if statistically significant for the adverse event.

The absence of a particular potentially modifiable comorbidity was used as a reference for the comorbidity. Neuropathic pain models were not shown because they were not significant as a whole. Bold *p* values indicate statistical significance.

Std. error, standard error; CI, confidence interval.

Discussion {#s009}
==========

Of the 444 patients studied, 79% experienced at least one AE and 38% experienced three or more, which correlates well with an earlier study using the SAVES instrument in which 77% of patients experienced at least one AE.^[@B2]^ Compared with that study,^[@B2]^ we found the most common AEs experienced were UTI, pneumonia, NP, delirium, and cardiac arrest/failure/arrhythmia, and similar nonmodifiable risk factors for developing an AE included age at time of injury, gender, and severity of injury. Potentially modifiable comorbidities including psychiatric conditions were associated with increased risk of pneumonia, while substance use/withdrawal conditions were associated with elevated risk of delirium.

Relation to previous literature {#s010}
-------------------------------

The literature reports lower rates of AEs, but these studies are retrospective in nature compared to the prospective SAVES method, which has demonstrated improved capture of AEs, twice as many when compared with chart extraction, and has excellent inter- and intraobserver reliability.^[@B8],[@B26],[@B29]^ Our study demonstrated a higher incidence of AEs than in the previous study by Street and colleagues^[@B2]^ who also used the SAVES method ([Table 4](#T4){ref-type="table"}). A more rigorous schedule of SAVES data collection over time may explain the increase in reported AEs observed in this study.

In our study, older age and more severe injury were significant nonmodifiable risk factors for experiencing a higher number of any AEs. The association between AEs in older patients with tSCI has been described previously,^[@B2],[@B9],[@B19]^ with an earlier study finding an incidence of AEs in 57.1% of older patients compared to 33.3% in younger patients.^[@B30]^ Increased age was also correlated with risk of AEs in earlier work at the study site.^[@B7]^ In terms of injury severity, when neurologic function was assessed in previous studies, 33.5% of patients with incomplete injuries (AIS B/C/D) were reported to experience at least one AE, compared with 59.5% of those with complete injuries (AIS A).^[@B30]^ Age and less severe initial AIS have been used in a recent clinical prediction model for long-term functional outcome after tSCI.^[@B31]^

The most common AEs identified in our study were UTI (42.8%), pneumonia (39.2%), NP (31.5%), delirium (18.2%), cardiac arrest/failure/arrhythmia (15.3%), dysphasia (12.6%), systemic infections (12.2%), and PU (11%), coinciding with previous literature that also reported high rates of cardiac complications and infections after SCI.^[@B10],[@B19],[@B30]^

Age, gender, injury severity and level identified in our study as nonmodifiable risk factors for experiencing the most common AEs were comparable with other studies. Interestingly, risk of PU was associated only with injury severity, a trend that was also observed in the earlier study in which motor score was used as a measure of injury severity.^[@B2]^ Injury severity has been consistently found to be a significant risk factor for PU^[@B11],[@B25]^ and is one of the 18 predictive risk factors for PU in persons with SCI identified in a recent systematic review.^[@B32]^ Age and gender were not found to part of the key predictive risk factors for PU development, similar to our study.^[@B32]^

The finding that older age, being female, and having more severe injuries presents a higher risk factor for UTI reported in this study aligns with existing studies for the SCI population,^[@B10]^ as well as for the community-dwelling population in which UTI is found to be more common in older women, specifically those who are post-menopausal^[@B33]^ revealing a possible biological mechanism underlying the development for UTI.

Implications {#s011}
------------

We aimed to identify potentially modifiable pre-existing comorbidities or conditions that are associated with acute AEs; the term "modifiable" is not intended to mean completely fixable, or preventative, rather potentially "managed" in hopes of reducing the impact of pre-existing conditions on AEs risk given the high frequency of AEs in the acute period. After adjusting for age, injury severity and level, and gender if statistically significant, substance use/withdrawal and psychiatric comorbidities were identified as potentially modifiable risk factors for AEs including delirium and pneumonia. Opportunity exists to develop clinical algorithms that include these types of risk factors to reduce the incidence and impact of AEs. Further, effort has been invested at our institution to identify and develop a multidisciplinary management strategy in response to our acute AE rate in patients with tSCI. We anticipate that these initiatives will lead to a significant decrease in morbidity and length of stay associated with tSCI.^[@B2],[@B7]^ A report of any early data regarding the impact of these interventions on potentially modifiable comorbidities is not within the scope of this study.

Alcohol intoxication at time of injury has been identified in 20% of all tSCIs between 2000 and 2006 by the National Trauma Data Bank in the United States.^[@B34]^ Our study did not distinguish intoxication at the time of injury from substance (alcohol/drug) use or withdrawal. We did, however, identify substance use or withdrawal, considered to be potentially modifiable, as a significant risk factor for delirium. To our knowledge, this is the first study to report it as a risk factor for acute AEs in those with tSCI. This is of significant clinical importance because delirium has been shown to increase length of hospital stay, post-discharge institutionalization, long-term cognitive deficits, and mortality.^[@B12],[@B35],[@B36]^ Further, delirium will become an increasing problem because of advancing age at time of SCI.^[@B12]^ Although delirium is often multifactorial and difficult to detect,^[@B37],[@B38]^ self-reported alcohol use has been established as a component of noncardiac surgery delirium risk scores.^[@B39]^ Early recognition and management of alcohol/drug use or withdrawal through multicomponent strategies of nursing interventions and pharmacological prophylaxis may mitigate its impact on acute AEs.

Our findings of psychiatric comorbidities identified as significant risk factors for pneumonia corroborate literature showing that antipsychotics use increases the risk of pneumonia,^[@B40]^ and that readmission within 30 days because of pneumonia is more common in persons with psychiatric comorbidities.^[@B41]^ Recognizing and managing psychiatric comorbidities after tSCI will be crucial especially for those who have multiple trauma and invasive medical procedures, which are common for SCI, because these factors have been shown to significantly increase the pneumonia incidence.^[@B42]^ Future studies examining the possible additive effect of these factors and psychiatric comorbidities on pneumonia deserve attention because pneumonia is the leading cause of death after acute SCI^[@B43]^ and is associated with poor neurological outcome, longer stay in hospital, and increased rate of discharge to a skilled nursing facility.^[@B44]^

Next steps/gaps {#s012}
---------------

Results from this study will be applied to the Access to Care and Timing (ACT) simulation model of tSCI care^[@B45]^ to enhance the prediction of complications. Injury characteristics (ISS, GCS) that have been associated with AEs developing were not included in this study but are important to consider in future studies. Further investigation of the NP data will be needed because the NP models from the current analysis were not significant, making it difficult to examine its association with nonmodifiable and modifiable factors reliably. This might be attributed to the complexity of its pathogenesis and clinical diagnosis, and is consistent with the high heterogeneity in reporting the prevalence of NP concluded by a recent systematic review and meta-analysis.^[@B46]^

At the study site, a clinical protocol to screen, diagnose, and manage NP has been developed with a multidisciplinary team,^[@B47]^ and full implementation of the protocol will help improve clinical understanding and management of NP. Recognizing that risk of AEs is multifactorial, future work using network analysis is planned to explore the interactions between each top AE and various patient, neurological, functional, and clinical (comorbidities and other AEs) factors.

Limitations {#s013}
-----------

This study does not report on intraoperative events or long-term outcomes because this was not the aim of this study. All patients received appropriate medical management of AEs upon their recognition in keeping with standard medical practice. This study was set forth to (1) validate existing interactions between patient factors (nonmodifiable factors) and common AEs initially identified by Street and associates^[@B2]^ in the acute phase of SCI care; and (2) identify potentially modifiable comorbid conditions related to previously identified common AEs. It did not intend to investigate the management strategies of patient care with respect to comorbidities and the change in patient outcome.

The common AEs evaluated represent those identified by a pre-existing study from a smaller sample. This does represent a limitation in that not all of the most common AEs from this study were assessed with the same scrutiny. Further, it does not consider all comorbidities such as smoking and anemia; the intent of the current study was to explore the relation of a selection of comorbidities and complications as a first step in exploring the possible opportunity to address potentially modifiable comorbidities to prevent or mitigate complications. Analysis of all comorbidities and complications would also likely introduce higher family-wise error rate because of performing multiple hypotheses tests.

The study site is a quaternary referral center with established protocols and multidisciplinary teams involved in all stages of patient care; however, being a single center may minimize the variability in patient factors, which could limit generalizability. Further, the rigorous prospective SAVES method is complex and resource intensive; this may not be feasible at all centers and therefore difficult to implement into practice. To facilitate the implementation of SAVES into practice, a shortened version of SAVES is being validated and may address this limitation.

Conclusion {#s014}
==========

We identified a substantially higher incidence of acute AEs in patients with tSCI compared with the literature; however, the most common AEs identified in this study are consistent with the literature. Age, gender, and injury severity were nonmodifiable risk factors for AEs. The focus of this article was to identify modifiable conditions relating to post-injury AEs in patients with tSCI; these included substance use/withdrawal and psychiatric conditions. Although not considered "fixable," this study suggests an opportunity to address potentially modifiable conditions associated with AEs. Future development of clinical algorithms that screen for these types of risk factors should be considered in the effort to reduce incidence of AEs.
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